COR
Cencora, Inc. · Healthcare · Medical - Distribution
Momentum-inputs (vergelijkbare managers):
breedte van houders +4.3% ·
aandelenstroom +4.2% ·
netto nieuwe posities 0.0%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 466.89K | $143.79M | n/a | n/a |
| Q2 2026 | 161 | 0 | 138.36M | $39.16B | +5 | −6 |
| Q1 2026 | 165 | -4 | 143.75M | $45.15B | +4 | −9 |
| Q4 2025 | 168 | -1 | 154.98M | $52.35B | +1 | −1 |
| Q3 2025 | 24 | +1 | 95.47M | $29.83B | +1 | −1 |
| Q2 2025 | 21 | 0 | 79.61M | $23.87B | n/a | n/a |
| Q1 2025 | 18 | +1 | 37.02M | $10.29B | +2 | −1 |
| Q4 2024 | 17 | 0 | 34.14M | $7.67B | n/a | n/a |
| Q3 2024 | 16 | 0 | 25.36M | $5.70B | n/a | n/a |
| Q2 2024 | 16 | n/a | 24.85M | $5.60B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 23.40M | +4.1% | $7.31B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 19.78M | +5.7% | $6.18B | 0.1% | ▲ Add | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 9.36M | n/a | $2.92B | 0.1% | n/c | 1 | SEC ↗ ×42 |
| 4 | State Street Global Advisors ✦ (passief) | 9.19M | +9.3% | $2.87B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 7.72M | -0.9% | $2.41B | 0.3% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passief) | 5.29M | +10.5% | $1.65B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 3.97M | +3.0% | $1.24B | 0.2% | ▲ Add | 6 | SEC ↗ ×8 |
| 8 | Morgan Stanley ✦ | 3.34M | n/a | $1.04B | 0.1% | n/c | 1 | SEC ↗ ×16 |
| 9 | Fidelity (FMR) ✦ | 3.31M | +5.7% | $1.03B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 10 | Marshall Wace ✦ | 2.00M | +518.9% | $623.53M | 0.7% | ▲ Add | 6 | SEC ↗ ×3 |
| 11 | Viking Global Investors ✦ | 1.78M | -14.6% | $555.72M | 1.4% | ▼ Trim | 3 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 1.60M | n/a | $500.95M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 13 | Citadel Advisors ✦ | 1.24M | -30.4% | $387.06M | 0.3% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Arrowstreet Capital ✦ | 1.02M | +5.6% | $318.37M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 15 | Millennium Management ✦ | 985.92K | +65.6% | $308.13M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 802.69K | -8.9% | $247.62M | 0.2% | ▼ Trim | 6 | SEC ↗ ×5 |
| 17 | D. E. Shaw & Co. ✦ | 230.36K | +135.3% | $72.00M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 18 | Adage Capital Partners ✦ | 176.30K | +8.0% | $55.10M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 147.21K | -64.7% | $46.01M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 20 | Bridgewater Associates ✦ | 50.33K | -55.4% | $15.73M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 45.67K | +3.4% | $14.27M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 27.60K | Nieuw | $8.63M | 0.0% | New | 1 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 10.07K | -98.5% | $3.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 1.36K | +47.2% | $424,987 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Renaissance Technologies | $8.63M | 0.0% |
Verlaten
| Norges Bank | $695.22M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,407 houders, 152.27M aandelen, $41.91B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 986 aand · $298,935
Director · 1.28K aand · $411,264
Officer · 985 aand · $321,080
Officer · 11.30K aand · $3.66M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie